En Es
Categories

Industry News

Global POC Infectious Disease Market to Reach USD 1.9 Billion by 2025

By Labmedica International staff writers
09 Jan 2018

Image: The global point-of-care infectious disease diagnostics/testing market is expected to reach USD 1.90 billion by 2025 (Photo courtesy of iStock).The global point-of-care (POC) infectious disease diagnostics/testing market is expected to reach USD 1.90 billion by 2025, as the emerging trend of patient-centric services and increase in complicated infectious disorders drives an upsurge in the demand for portable and accurate detection devices.

These are the latest findings of Research and Markets, (Dublin, Ireland), a global market research company.

Portable devices with the potential to enable rapid detection of infectious diseases are revolutionizing patient care and driving the growing demand for decentralized testing settings. Additionally, increased R&D investments for the development of new products are expected to further drive the POC infectious disease diagnostics/testing market. For instance, an EU project research team has developed a new lab-on-a-disc' technology that aids in the diagnosis of various infectious diseases, including malaria. Through POC treatment, the technology enables faster diagnosis and allows precise administration of drugs, thereby driving its adoption.

HIV POC is estimated to account for the largest share of the POC infectious disease diagnostics/testing market due to the rising incidence rate of the disease. Companies are also adopting a quality management approach towards the introduction of novel tests for HIV diagnosis. TB and drug resistant TB are anticipated to witness lucrative demand over the coming years on account of their rising incidence rate, fueled further by the implementation of fully or partially integrated nano/microscale technologies for developing drug resistant TB diagnostic devices.

The demand for the development of inexpensive, rapid, simple, and accurate tests capable of simultaneously detecting multiple biomarkers is expected to contribute to the market growth. Moreover, advances in bio sensing technology for early detection with sensitivity are expected to drive revenue for the market players over the coming years.

Geographically, North America dominates the global market for POC infectious disease diagnostics/testing, due to adequate administration support, well-established healthcare framework, and extensive R&D upgradation in the region. However, the Asia Pacific market is expected to record the fastest growth over the forecast period due to the rising incidence and prevalence rates of infectious diseases in the region as well as favorable government support.

Related Links:
Research and Markets



E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

19 Jul 2018
Global Ambulatory Surgical Centers Market to Reach USD 97 Billion by 2024
The global ambulatory surgical centers (ASCs) market is estimated to have been valued at USD 77.1 billion in 2017 and is expected to grow at a CAGR of 3.5% to reach USD 97.3 billion by 2024, driven mainly by the growing number of surgeries performed in ASCs and increasing accidental cases. Some key advantages of using ASCs such as the personal attention received by patients and lack of exposure to a wide range of infections will also aid the market growth over the coming years.
Read More
19 Jul 2018
Global Critical Care Diagnostics Market to Reach USD 1.3 Billion by 2024
The global critical care diagnostics (CCD) market is estimated to have been valued at USD 837.6 million in 2015 and is expected to reach USD 1.3 billion by 2024, driven by increasing awareness among physicians, patients’ requirements for cost-efficient, rapid, and accurate diagnostic tests, and technological advancements. However, the high costs of these tests and scarcity of skilled labor for handling new platforms pose a challenge to the market growth.
Read More
16 Jul 2018
Guerbet and IBM Watson Health to Jointly Develop AI Software
Guerbet, which specializes in contrast agents and solutions for diagnostic and interventional medical imaging, has signed an agreement with IBM Watson Health to jointly develop an artificial intelligence (AI) software solution for supporting liver cancer diagnostics and care.
Read More
12 Jul 2018
Global Surgical Tables and Lights Market to Surpass USD 1.8 Billion by 2026
The global surgical tables and lights market was valued at more than USD 1.30 billion in 2017 and is projected to grow at a CAGR of over 3.0% over 2018 to 2026 to surpass USD 1.80 billion by 2026. The demand for surgical tables and lights during the forecast period is likely to be driven by developing health care infrastructure in the emerging countries and the introduction of technologically-advanced surgical tables and lights by the market players. However, constant evolution in the surgical tables and lights segment, with the introduction of new features and designs has led to high prices of these products, thereby acting as a major restraint to the market growth.
Read More
12 Jul 2018
Global Endoscopy Ultrasound Market to Reach USD 1 Billion by 2026
The global endoscopy ultrasound market was valued at approximately USD 650 million in 2017 and is expected to grow at a CAGR of over 5.0% from 2018 to 2026 to reach USD 1.0 billion by 2026. The market growth is being driven by an increase in the incidence of gastrointestinal (GI) cancers, rise in endoscopy ultrasound applications as a diagnostic and therapeutic tool for GI cancers and other pancreatic conditions, and growing number of new and advanced products introduced in the global market. However, the lack of training and educational programs conducted and implemented globally is leading to a shortage of adequately trained professionals who are adept at performing endoscopy ultrasound techniques. This has resulted in a gap between demand for and supply of endoscopy ultrasound procedures globally, thereby restraining market growth.
Read More
10 Jul 2018
Global Contrast Injectors Market Driven by Increasing Chronic Diseases
The global contrast injectors market is expected to grow at a CAGR of 5.07% over the forecast period 2018-2022, driven primarily by increasing chronic diseases. In recent years, there has been a significant increase in the demand for medical devices such as contrast injectors for treating such chronic illness arising from the growing incidence of cardiovascular diseases as a result of obesity and increase in blood pressure. These are the latest findings of Research and Markets, a global market research company.
Read More
05 Jul 2018
EKF Diagnostics Releases Educational Guide to Good Capillary Blood Sampling
Global in vitro diagnostics company EKF Diagnostics has published an educational guide, which provides a quick overview of capillary blood sampling best practice. The new guide aims to help health care professionals understand the common causes of pre-analytical errors and reduce their impact on hemoglobin results.
Read More
05 Jul 2018
New AI Software Could Reduce Patient Time at Hospitals
Canadian researchers have developed an innovative "virtual assistant" — an Artificial Intelligence (AI) health monitoring solution for an existing secure health monitoring platform — to help patients, their healthcare providers, and caregivers remotely manage chronic conditions such as diabetes, hypertension, and heart failure. The virtual assistant, developed by the National Research Council of Canada and Greybox Solutions Inc. aims to reduce the considerable time spent in hospitals and healthcare centers by millions of Canadians affected by chronic illnesses.
Read More
04 Jul 2018
Researchers Use AI to Improve Mammogram Interpretation
A team of researchers at the Department of Energy’s Oak Ridge National Laboratory successfully used artificial intelligence to improve understanding of the cognitive processes involved in image interpretation. Their work, which was published in the Journal of Medical Imaging, will help reduce errors in the analyses of diagnostic images by health professionals and has the potential to improve health outcomes for women affected by breast cancer.
Read More
Copyright © 2000-2018 TradeMed.com. All rights reserved. | Terms And Conditions